Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis

Recently, modified fibrosis-4 index (mFIB-4) and the easy liver fibrosis test (eLIFT) were developed for predicting liver fibrosis in chronic liver disease patients. We evaluated whether the 2 tests can predict hepatocellular carcinoma (HCC) risk in alcoholic liver cirrhosis (ALC) patients. A retros...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Medicine (Baltimore)
Päätekijät: Kim, Ji Hyun, Lee, Minjong, Park, Seung Woo, Kang, Myungho, Kim, Minjeong, Lee, Sang Hoon, Kim, Tae Suk, Park, Jin Myung, Choi, Dae Hee
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wolters Kluwer Health 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283079/
https://ncbi.nlm.nih.gov/pubmed/30508959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013438
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia